Neurotoxins from Australo-Papuan elapids: A biochemical and pharmacological perspective

Critical Reviews in Toxicology

Volumn 38, Issue 1, 2008, Pages 73-86

  Kuruppu, Sanjaya ^a   Smith, A Ian ^a   Isbister, Geoffrey K ^b   Hodgson, Wayne C ^a  

^a MONASH UNIVERSITY   (Australia)

^b MENZIES SCHOOL OF HEALTH RESEARCH   (Australia)

Author keywords

Antivenom; Elapid; Envenoming; Neuromuscular Junction; Neurotoxin; Postsynaptic; Presynaptic; Snake

Indexed keywords

ALPHA BUNGAROTOXIN; COBROTOXIN; NEOSTIGMINE; NEUROTOXIN; SNAKE VENOM; SURAMIN; VENOM ANTISERUM;

COMPARATIVE STUDY; ENVENOMATION; HUMAN; LD 50; MEDICAL RESEARCH; NEUROTOXICITY; NONHUMAN; PAPUA NEW GUINEA; PHARMACOLOGICAL PARAMETERS; REVIEW; SERODIAGNOSIS;

ANIMALS; ANTIVENINS; AUSTRALIA; ELAPID VENOMS; EXCITATORY POSTSYNAPTIC POTENTIALS; HUMANS; NEUROTOXINS; PAPUA NEW GUINEA; SNAKE BITES;

ELAPIDAE; MURINAE; SERPENTES; STORERIA DEKAYI;

EID: 37549053305     PISSN: 10408444     EISSN: 15476898     Source Type: Journal    
DOI: 10.1080/10408440701703964     Document Type: Review

References (117)

1. Abe, T., Alema, S., and Miledi, R. (1977). Isolation and characterization of presynaptically acting neurotoxins from the venom of Bungarus snakes. Eur. J. Biochem. 80:1-12.
2. Atassi, M.Z. (1995). Postsynaptic-neurotoxin-acetylcholine receptor interaction and the binding sites on the two molecules. In: Handbook of Natural Toxins 5: Reptile Venoms and Toxins, A Tu, ed. pp. 53-83. Marcel Dekker, New York.
3. Barchan, D., Ovadia, M., Kochva, E., and Fuchs, S. (1995). The binding site of the nicotinic acetylcholine receptor in animal species resistant to α-bungarotoxin. Biochemistry 34:9172-9176.
4. 2 Enzymes: Structure, Function and Mechanism, R.M Kini, ed., pp. 268-285. John Wiley & Sons, Chichester.
5. Broad, A.J., Sutherland, S.K., and Coulter, A.R. (1979). The lethality in mice of dangerous Australian and other snake venom. Toxicon 17:661-664.
6. Cadene, M., Duranton, J., North, A., Si-Tahar, M., Chignard, M., and Bieth, J.G. (1997). Inhibition of neutrophil serine proteinases by suramin. J. Biol. Chem. 272:9950-9955.
7. Castilonia, R.R., Pattabhiraman, T.R., and Russell, F.E. (1980). Neuromuscular blocking effects of Mojave rattlesnake (Crotalus scutulatus scutulatus) venom. Proc. West. Pharmacol. Soc. 23:103-106.
8. Chang, C.C, Lee, J.D., Eaker, D., and Fohlman, J. (1977). The presynaptic neuromuscular blocking action of taipoxin. A comparison with β-bugarotoxin and crotoxin. Toxicon 15:571-576.
9. 2 activity in snake venoms. Proc. Natl. Sci. Counc. Repub. China B 9:126-142.
10. Chang, C.C., and Lee, C.Y. (1963). Isolation of neurotoxins from the venom of Bungarus multicinctus and their modes of neuromuscular blocking action. Arch. Int. Pharmacodyn. Ther. 144:241-257.
11. Changeux, J.P., Kasai, M., and Lee, C.Y. (1970). Use of a snake venom toxin to characterize the cholinergic receptor protein. Proc. Natl. Acad. Sci. USA 67:1241-1247.
12. Chetty, N., Du, A., Hodgson, W.C., Winkel, K., and Fry, B.G. (2004). The in vitro neuromuscular activity of Indo-Pacific sea-snake venoms: Efficacy of two commercially available antivenoms. Toxicon 44:193-200.
13. Chiappinelli, V.A. (1991). κ-Neurotoxins and α-neurotoxins: Effects on neuronal nicotinic acetylcholine receptors. In: Snake Toxins, A.L. Harvey, ed., pp. 223-258. Pergamon Press, New York.
14. Chiappinelli, V.A. (1993). Neurotoxins acting on acetylcholine receptors In: Natural and Synthetic Neurotoxins, A.L. Harvey, ed., pp. 65-128. Academic Press, London.
15. Chicheportiche, R., Vincent, J.P., Kopeyan, C., Schweitz, H., and Lazdunski, M. (1975). Structure-function relationship in the binding of snake neurotoxins to the torpedo membrane receptor. Biochemistry 14:2081-2091.
16. Christopoulos, A., Parsons, A. M., Lew, M. J., and El-Fakahany, E. E. (1999). The assessment of antagonist potency under conditions of transient response kinetics. Eur. J. Pharmacol. 382:217-227.
17. Clarke, C., Kuruppu, S., Reeve, S., Smith, A.I., and Hodgson W.C (2006). Oxylepitoxin-1, a reversible neurotoxin from the venom of the inland taipan (Oxyuranus microlepidotus). Peptides 27:2655-2660.
18. Comadira, G.P., and Green, D. (1995). Three cases of envenomation by Stephen's banded snakes. Emerg. Med. 7:15-18.
19. Crachi, M.T., Hammer, L.W., and Hodgson, W.C. (1999a). The effects of antivenom on the in vitro neurotoxicity of venoms from the taipans Oxyuranus scutellatus, Oxyuranus microlepidotus and Oxyuranus scutellatus canni. Toxicon 37:1771-1778.
20. Crachi, M.T., Hammer, L.W., and Hodgson, W.C. (1999b). A pharmacological examination of venom from the Papuan taipan (Oxyuranus scutellatus canni). Toxicon 37:1721-1734.
21. Currie, B. (1999). A prospective study of snakebite in tropical Australia. Aust. NZ J. Med. 29:602.
22. Currie, B.J. (2000). Snakebite in tropical Australia, Papua New Guinea and Irian Jaya. Emerg. Med. 12:285-294.
23. 2, β-bungarotoxin: Its clinical significance. Am. J. Pathol. 154:447-455.
24. Dreyer, F., and Penner, R. (1987). The actions of presynaptic snake toxins on membrane currents of mouse motor nerve terminals. J. Physiol. 386:455-463.
25. Dufton, M.J., and Harvey, A.L. (1989). The long and the short of snake toxins. Trends Pharmacol. Sci. 10:258-259.
26. Endo, T., and Tamiya, N. (1991). Structure-function relationships of postsynaptic neurotoxins from snake venoms. In: Snake Toxins, A.L Harvey, ed., pp.165-222. Pergamon Press, New York.
27. Eng, J., Kleinman, W.A., Singh, L., Singh, G., and Raufman, J.P. (1992). Isolation and characterization of exendin-4, an exendin-3 analogue, from Heloderma suspectum venom. Further evidence for an exendin receptor on dispersed acini from guinea pig pancreas. J. Biol. Chem. 267:7402-7405.
28. Esquerdera, J., Solsana, C., and Marsal, J. (1982). Binding of β-bungarotoxin to Torpedo electric organ synaptosomes. A high resoloution autoradiographic study. Neuroscience 7:751-758.
29. + channels. Toxicon 39:1871-1882.
30. 2 Enzymes: Struture, Function and Mechanism, R.M Kini, ed., pp. 413-454. John Wiley & Sons, West Sussex.
31. Fohlman, J. (1979). Comparison of two highly toxic Australian snake venoms: the taipan (Oxyuranus scutellatus scutellatus) and the fierce snake (Parademansia microlepidotus). Toxicon 17:170-172.
32. Fohlman, J., Eaker, D., Dowdall, M.J., Lullmann-Rauch, R., Sjodin, T., and Leander, S. (1979). Chemical modification of taipoxin and the consequences for phospholipase activity, pathophysiology, and inhibition of high-affinity choline uptake. Eur. J. Biochem. 94:531-540.
33. Fohlman, J., Eaker, D., Karlsoon, E., and Thesleff, S. (1976). Taipoxin, an extremely potent presynaptic neurotoxin from the venom of the australian snake taipan (Oxyuranus s. scutellatus). Isolation, characterization, quaternary structure and pharmacological properties. Eur. J. Biochem. 68:457-469.
34. Fohlman, J., Lind, P., and Eaker, D. (1977). Taipoxin, an extremely potent presynaptic snake venom neurotoxin. Elucidation of the primary structure of the acidic carbohydrate-containing taipoxin-subunit, a prophospholipase homolog. FEBS Lett. 84:367-371.
35. Francis, B., Williams, E.S., Seebart, C., and Kaiser, I.I., (1993). Proteins isolated from the venom of the common tiger snake (Notechis scutatus scutatus) promote hypotension and hemorrhage. Toxicon 31:447-458.
36. Fry, B.G., Lumsden, N.G., Wuster, W., Wickramaratna, J.C., Hodgson, W.C., and Kini, R.M. (2003). Isolation of a neurotoxin (α-colubritoxin) from a nonvenomous colubrid: Evidence for early origin of venom in snakes. J. Mol. Evol. 57:446-452.
37. Fry, B.G., Wickramaratna, J.C., Jones, A., Alewood, P.F., and Hodgson, W.C. (2001). Species and regional variations in the effectiveness of antivenom against the in vitro neurotoxicity of death adder (Acanthophis) venoms. Toxicol. Appl. Pharmacol. 175:140-148.
38. Gold, B.S. (1996). Neostigmine for the treatment of neurotoxicity following envenomation by the Asiatic cobra. Ann. Emerg. Med. 28:87-89.
39. Gong, N., Armugam, A., and Jeyaseelan, K. (1999). Postsynaptic short-chain neurotoxins from Pseudonaja textilis. cDNA cloning, expression and protein characterization. Eur. J. Biochem. 265:982-989.
40. Grant, G.A., and Chiappinelli, V.A. (1985). kappa-Bungarotoxin: Complete amino acid sequence of a neuronal nicotinic receptor probe. Biochemistry 24:1532-1537.
41. Greer, A. (1997). The biology and the evolution of Australian snakes. Surrey Beatty & Sons Pty Limited.
42. Grutter, T., and Changeux, J.P. (2001). Nicotinic receptors in wonderland. Trends Biochem. Sci. 26:459-463.
43. Gunja, N., Ling, M.L., Dowsett, R.P., Murray, L., and Isbister, G.K. (2007). Antivenom and neostigmine failure in death adder envenoming. Clin. Toxicol. 45:389.
44. Halpert, J., and Eaker, D. (1975). Amino acid sequence of a presynaptic neurotoxin from the venom of Notechis scutatus scutatus (Australian tiger snake). J. Biol. Chem. 250:6990-6997.
45. Halpert, J., and Eaker, D. (1976). Isolation and amino acid sequence of a neurotoxic phospholipase A from the venom of the Australian tiger snake Notechis scutatus scutatus. J. Biol. Chem. 251:7343-7347.
46. Halpert, J., Fohlman, J., and Eaker, D. (1979). Amino acid sequence of a postsynaptic neurotoxin from the venom of the Australian tiger snake Notechis scutatus scutatus. Biochimie 61:719-723.
47. Harris, J.B. (1991). Phospholipases in snake venoms and their effects on nerve and muscle. In: Snake Toxins, A.L. Harvey, ed., pp. 91-129. Pergamon Press, New York.
48. Harris, J.B. (1997). Toxic phospholipases in snake venom: An introductory review. Symp. Zool. Soc. Lond. 70:235-250.
49. 2, notexin and taipoxin. Exp. Neurol. 161:517-526.
50. Harvey, A.L., Barfaraz, A., Thomson, E., Faiz, A., Preston, S., and Harris, J.B. (1994). Screening of snake venoms for neurotoxic and myotoxic effects using simple in vitro preparations from rodents and chicks. Toxicon 32:257-265.
51. Hodgson, W.C., Dal Belo, C.A., and Rowan, E.G. (2007). The neuromuscular activity of paradoxin: a presynaptic neurotoxin from the venom of the inland taipan (Oxyuranus microlepidotus). Neuropharmacology 52:1229-1236.
52. Hodgson, W.C., Eriksson, C.O., Alewood, P.F., and Fry, B.G. (2003). Comparison of the in vitro neuromuscular activity of venom from three Australian snakes (Hoplocephalus stephensi, Austrelaps superbus and Notechis scutatus): Efficacy of tiger snake antivenom. Clin. Exp. Pharmacol. Physiol. 30:127-132.
53. Hodgson, W.C., and Wickramaratna, J. C. (2002). In vitro neuromuscular activity of snake venoms. Clin. Exp. Pharmacol. Physiol. 29:807-814.
54. Howard, B.D., and Wu, W.C. (1976). Evidence that β-bungarotoxin acts at the exterior of nerve terminals. Brain Res. 103:190-192.
55. Ingels, M. (2001). Snakes and other reptiles. In: Toxicology Secrets, L. Ling., R. Clark., T. Erickson., and J. Trestrail., eds., pp. 261-269. Hanley & Belfus, Philadelphia.
56. Isbister, G.K., O'Leary, M.A., Schneider, J.J., Brown, S.G., and Currie, B.J. (2007). Efficacy of antivenom against the procoagulant effect of Australian brown snake (Pseudonaja sp.) venom: In vivo and in vitro studies. Toxicon 49:57-67.
57. Jones, R.G., Lee, L., and Landon, J. (1999). The effects of specific antibody fragments on the 'irreversible' neurotoxicity induced by Brown snake (Pseudonaja) venom. Br. J. Pharmacol. 126:581-584.
58. Kamenskaya, M.A., and Thesleff, S. (1974). The neuromuscular blocking action of an isolated toxin from the elapid (Oxyuranus scutellactus). Acta Physiol. Scand. 90:716-724.
59. Kannan, K.S., S, Ramanadham, M., and Eaker, D. (1981). Structure of presynaptic toxins: Crystallization and preliminary X-ray diffraction data on Notechis II-5, a presynaptic toxin phospholipase. J. Biosci. 3:29-31.
60. Karlsson, E., Eaker, D., and Ryden, L. (1972). Purification of a presynaptic neurotoxin from the venom of the australian tiger snake Notechis scutatus scutatus. Toxicon 10:405-413.
61. Keogh, J.S., Shine, R., and Donnellan, S. (1998). Phylogenetic relationships of terrestrial Australo-Papuan elapid snakes (subfamily Hydrophiinae) based on cytochrome b and 16S rRNA sequences. Mol. Phylogenet. Evol. 10:67-81.
62. Kim, H.S., and Tamiya, N. (1981). Isolation, properties and amino acid sequence of a long-chain neurotoxin, Acanthophis antarcticus b, from the venom of an Australian snake (the common death adder, Acanthophis antarcticus). Biochem. J. 193:899-906.
63. Kuruppu, S., Fry, B. G., and Hodgson, W. C. (2005a). Presynaptic neuromuscular activity of venom from the brown-headed snake (Glyphodon tristis). Toxicon 45:383-388.
64. Kuruppu, S., Reeve, S., Banerjee, Y., Kini, R.M., Smith, A.I., and Hodgson, W.C. (2005). Isolation and pharmacological characterization of cannitoxin, a presynaptic neurotoxin from the venom of the Papuan Taipan (Oxyuranus scutellatus canni). J. Pharmacol. Exp. Ther. 315:1196-1202.
65. Kuruppu, S., Reeve, S., Smith, A.I., and Hodgson, W.C. (2005b). Isolation and pharmacological characterisation of papuantoxin-1, a postsynaptic neurotoxin from the venom of the Papuan black snake (Pseudechis papuanus). Biochem. Pharmacol. 70:794-800.
66. Lalloo, D.G., Trevett, A.J., Black, J., Mapao, J., Saweri, A., Naraqi, S., Owens, D., Kamiguti, A.S., Hutton, R.A., Theakston, R.D., and Warrell, D.A. (1996). Neurotoxicity, anticoagulant activity and evidence of rhabdomyolysis in patients bitten by death adders (Acanthophis sp.) in southern Papua New Guinea. Q. J. Med. 89:25-35.
67. Lalloo, D.G., Trevett, A.J., Korinhona, A., Nwokolo, N., Laurenson, I.F., Paul, M., Black, J., Naraqi, S., Mavo, B., and Saweri, A. (1995). Snake bites by the Papuan taipan (Oxyuranus scutellatus canni): Paralysis, hemostatic and electrocardiographic abnormalities, and effects of antivenom. Am. J. Trop. Med. Hyg. 52:525-531.
68. 2. Trends Pharmacol. Sci. 20:162-170.
69. Lee, C.Y. (1972). Chemistry and pharmacology of polypeptide toxins in snake venoms. Annu. Rev. Pharmacol. 12:265-286.
70. Lew, M.J., and Angus, J.A. (1995). Analysis of competitive agonist-antagonist interactions by nonlinear regression. Trends Pharmacol. Sci. 16:328-337.
71. Lin-Shiau, S.Y., and Lin, M.J. (1999). Suramin inhibits the toxic effects of presynaptic neurotoxins at the mouse motor nerve terminals. Eur. J. Pharmacol. 382:75-80.
72. Lind, P. (1982). Amino-acid sequence of the beta 1 isosubunit of taipoxin, an extremely potent presynaptic neurotoxin from the Australian snake taipan (Oxyuranus s. scutellatus). Eur. J. Biochem. 128:71-75.
73. Lind, P., and Eaker, D. (1982). Amino-acid sequence of the alpha-subunit of taipoxin, an extremely potent presynaptic neurotoxin from the Australian snake taipan (Oxyuranus s. scutellatus). Eur. J. Biochem. 124:441-447.
74. Lumsden, N.G., Banerjee, Y., Kini, R.M., Kuruppu, S., and Hodgson, W.C. (2007). Isolation and characterization of rufoxin, a novel protein exhibiting neurotoxicity from venom of the psammophiine, Rhamphiophis oxyrhynchus (rufous beaked snake). Neuropharmacol. 52:1065-1070.
75. Lumsden, N.G., Fry, B.G., Ventura, S., Kini, R.M., and Hodgson, W.C. (2005). Pharmacological characterisation of a neurotoxin from the venom of Boiga dendrophila (mangrove catsnake). Toxicon 45:329-334.
76. Miljanich, G.P. (2004). Ziconotide: Neuronal calcium channel blocker for treating severe chronic pain. Curr. Med. Chem. 11:3029-3040.
77. 2 neurotoxins block nerve terminals? Trends Biochem. Sci. 25:266-270.
78. Murakami, M.T., Arruda, E.Z., Melo, P.A., Martinez, A.B., Calil-Elias, S., Tomaz, M.A., Lomonte, B., Gutierrez, J.M., and Arni, R.K. (2005). Inhibition of myotoxic activity of Bothrops asper myotoxin II by the anti-trypanosomal drug suramin. J. Mol. Biol. 350:416-426.
79. Nirthanan, S., Gao, R., Gopalakrishnakone, P., Gwee, M.C., Khoo, H.E., Cheah, L.S., and Manjunatha Kini, R. (2002). Pharmacological characterization of mikatoxin, an α-neurotoxin isolated from the venom of the New-Guinean small-eyed snake Micropechis ikaheka. Toxicon 40:863-871.
80. O'Leary, M.A., Schneider, J.J., Krishnan, B.P., Lavis, C., McKendry, A., Ong, L.K., and Isbister, G.K. (2007). Cross-neutralisation of Australian brown and tiger snake venoms with commercial antivenoms: Cross-reactivity or antivenom mixtures? Toxicon doi:10.1016/j.toxicon.2007.03.014
81. Paterson, D., and Nordberg, A. (2000). Neuronal nicotinic receptors in the human brain. Prog. Neurobiol. 61:75-111.
82. Pawlak, J., Mackessy, S.P., Fry, B.G., Bhatia, M., Mourier, G., Fruchart-Gaillard, C., Servent, D., Menez, R., Stura, E., Menez, A., and Kini, R.M. (2006). Denmotoxin, a three-finger toxin from the colubrid snake Boiga dendrophila (mangrove catsnake) with bird-specific activity. J. Biol. Chem. 281:29030-29041.
83. Pearson, J.A., Tyler, M.I., Retson, K.V., and Howden, M.E. (1993). Studies on the subunit structure of textilotoxin, a potent presynaptic neurotoxin from the venom of the Australian common brown snake (Pseudonaja textilis). The complete amino-acid sequences of all the subunits. Biochim. Biophys. Acta 1161:223-229.
84. Penner, R., and Dreyer, F. (1986). Two different presynaptic calcium currents in mouse motor nerve terminals. Pflugers Arch. 406:190-197.
85. 2 neurotoxins and lysophospholipid-fatty acid mixtures. Science 310:1678-1680.
86. Rigoni, M., Pizzo, P., Schiavo, G., Weston, A.E., Zatti, G., Caccin, P., Rossetto, O., Pozzan, T., and Montecucco, C. (2007). Calcium influx and mitochondrial alterations at synapses exposed to snake neurotoxins or their phospholipid hydrolysis products. J. Biol. Chem. 282:11238-11245.
87. 2 Enzymes: Structure, Function and Mechanism, R.M. Kini, ed., pp. 129-154. John Wiley & Sons, Chichester.
88. Rossetto, O., Morbiato, L., Caccin, P., Rigoni, M., and Montecucco, C. (2006). Presynaptic enzymatic neurotoxins. J. Neurochem. 97:1534-1545.
89. Rugolo, M., Dolly, J.O., and Nicholls, D.G. (1986). The mechanism of action of beta-bungarotoxin at the presynaptic plasma membrane. Biochem. J. 233:519-523.
90. Saez-Briones, P., Krauss, M., Dreger, M., Herrmann, A., Tsetlin, V.I., and Hucho, F. (1999). How do acetylcholine receptor ligands reach their binding sites? Eur. J. Biochem. 265:902-910.
91. 2 from Pseudechis porphyriacus (Australian red-bellied black snake). Toxicon 27:805-818.
92. Servent, D., Winckler-Dietrich, V., Hu, H.Y., Kessler, P., Drevet, P., Bertrand, D., and Menez, A. (1997). Only snake curaremimetic toxins with a fifth disulfide bond have high affinity for the neuronal alpha7 nicotinic receptor. J. Biol. Chem. 272:24279-24286.
93. Sheumack, D.D., Howden, M.E., and Spence, I. (1979). Isolation and partial characterisation of a lethal neurotoxin from the venom of the Australian death adder (Acanthophis antarcticus). Toxicon 17:609-616.
94. Sheumack, D.D., Spence, I., Tyler, M.I., and Howden, M.E. (1990). The complete amino acid sequence of a post-synaptic neurotoxin isolated from the venom of the Australian death adder snake Acanthophis antarcticus. Comp. Biochem. Physiol. B. 95:45-50.
95. 2 neurotoxins localize to produce their neuromuscular blocking effects. Toxicon 31:13-26.
96. Strong, P.N., Goerke, J., Oberg, S.G., and Kelly, R.B. (1976). beta-Bungarotoxin, a pre-synaptic toxin with enzymatic activity. Proc. Natl. Acad. Sci. USA 73:178-182.
97. 2 activity of textilotoxin, a potent toxin isolated from the venom of the Australian brown snake, Pseudonaja textilis. Toxicon 21:143-151.
98. Sutherland, S., and Tibballs, J. (2001). Australian Animal Toxins, The Creature, Their Toxins and Care of the Poisoned Patient. 2nd ed. Oxford University Press, Melbourne, Australia.
99. Takasaki, C. (1989). Amino acid sequence of a long-chain neurotoxin homologue, Pa ID, from the venom of an Australian elapid snake, Pseudechis australis. J. Biochem. (Tokyo) 106:11-16.
100. Takasaki, C., and Tamiya, N. (1985). Isolation and amino acid sequence of a short-chain neurotoxin from an Australian elapid snake, Pseudechis australis. Biochem. J. 232:367-371.
101. Tan, L.C., Kuruppu, S., Smith, A.I., Reeve, S., and Hodgson, W.C. (2006). Isolation and pharmacological characterisation of hostoxin-1, a postsynaptic neurotoxin from the venom of the Stephen's banded snake (Hoplocephalus stephensi). Neuropharmacology 51:782-788.
102. Trevett, A.J., Lalloo, D.G., Nwokolo, N.C., Naraqi, S., Kevau, I.H., Theakston, R.D., and Warrell, D.A. (1995). The efficacy of antivenom in the treatment of bites by the Papuan taipan (Oxyuranus scutellatus canni). Trans. R. Soc. Trop. Med. Hyg. 89:322-325.
103. Tyler, M.I., Retson-Yip, K.V., Gibson, M.K., Barnett, D., Howe, E., Stocklin, R., Turnbull, R.K., Kuchel, T., and Mirtschin, P. (1997). Isolation and amino acid sequence of a new long-chain neurotoxin with two chromatographic isoforms (Aa el and Ae e2) from the venom of the Australian death adder (Acanthophis antarcticus). Toxicon 35:555-562.
104. Tyler, M.I., Spence, I., Barnett, D., and Howden, M.E. (1987). Pseudonajatoxin b: Unusual amino acid sequence of a lethal neurotoxin from the venom of the Australian common brown snake, Pseudonaja textilis. Eur. J. Biochem. 166:139-143.
105. Utkin, Y.N., Kukhtina, V.V., Kryukova, E.V., Chiodini, F., Bertrand, D., Methfessel, C., and Tsetlin, V.I. (2001). "Weak toxin" from Naja kaouthia is a nontoxic antagonist of alpha 7 and muscle-type nicotinic acetylcholine receptors. J. Biol. Chem. 276:15810-15815.
106. van Oosterom, A.T., ten Bokkel Huinink, W.W., van der Burg, M.E., Vermorken, J.B., Willemse, P.H., and Neijt, J.P. (1991). Phase II clinical trial of doxifluridine in patients with advanced ovarian cancer. Eur. J. Cancer 27:747-749.
107. Waltenberger, J., Mayr, U., Frank, H., and Hombach, V. (1996). Suramin is a potent inhibitor of vascular endothelial growth factor. A contribution to the molecular basis of its antiangiogenic action. J. Mol. Cell. Cardiol. 28:1523-1529.
108. Warrell, D. (1996). Clinical features of envenoming from snake bites. In: Envenomings and Their Treatments, C. Bon, and M. Goyffon, eds., pp. 63-76. Foundation Marcel Merieux, Lyon.
109. Watt, G., Padre, L., Tuazon, L., Theakston, R.D. and Laughlin, L. (1988). Bites by the Philippine cobra (Naja naja philippinensis): Prominent neurotoxicity with minimal local signs. Am. J. Trop. Med. Hyg. 39(3):306-311.
110. Wickramaratna, J.C. (2003). A pharmacological characterisation of death adder (Acanthophis spp.) venoms and toxins. PhD dissertation, Department of Pharmacology, Monash University, Australia.
111. Wickramaratna, J.C., Fry, B. G., Loiacono, R. E., Aguilar, M. I., Alewood, P. F., and Hodgson, W. C. (2004). Isolation and characterization at cholinergic nicotinic receptors of a neurotoxin from the venom of the Acanthophis sp. Seram death adder. Biochem. Pharmacol. 68:383-394.
112. Wickramaratna, J.C., and Hodgson, W. C. (2001). A pharmacological examination of venoms from three species of death adder (Acanthophis antarcticus, Acanthophis praelongus and Acanthophis pyrrhus). Toxicon 39:209-216.
113. Wrogemann, K., and Pena, S.D. (1976). Mitochondrial calcium overload: A general mechanism for cell-necrosis in muscle diseases. Lancet 1:672-674.
114. Wuster, W., Dumbrell, A.J., Hay, C., Pook, C.E., Williams, D.J., and Fry, B.G. (2005). Snakes across the Strait: trans-Torresian phylogeographic relationships in three genera of Australasian snakes (Serpentes: Elapidae: Acanthophis, Oxyuranus, and Pseudechis). Mol. Phylogenet. Evol. 34:1-14.
115. Wyvratt, M.J. (1988). Evolution of angiotensin-converting enzyme inhibitors. Clin. Physiol. Biochem. 6:217-229.
116. Yang, C.C., Chang, L.S., and Wu, F.S. (1991). Venom constituents of Notechis scutatus scutatus (Australian tiger snake) from differing geographic regions. Toxicon 29:1337-1344.
117. Zamudio, F., Wolf, K.M., Martin, B.M., Possani, L.D., and Chiappinelli, V.A. (1996). Two novel alpha-neurotoxins isolated from the taipan snake, Oxyuranus scutellatus, exhibit reduced affinity for nicotinic acetylcholine receptors in brain and skeletal muscle. Biochemistry 35:7910-7916.